Randomized, double-blind placebo controlled trial of fish oil to decrease inflammation in pregnancy.
Name: Omega-3 Fish OilDescription: 800mg DHA and 1200mg EPA or the equivalent of a placebo PO (by mouth) once a day from enrollment (prior to 16 weeks gestation) until delivery.Type: Dietary Supplement
Omega-3 Fish Oil Placebo
Description: cytokine concentration in plasma, placenta and white adipose tissueMeasure: Decreased inflammation during human pregnancy Time: enrollment (8-16 weeks) to delivery
Description: insulin sensitivity as estimated by OGTTMeasure: Reduction of insulin resistance Time: enrollment (8-16 weeks) to delivery
There is one SNP
- Moderate or high titer IgG anticardiolipin antibodies or prolonged activated PTT or other indication of presence of lupus anticoagulant, homozygous for prothrombin gene (G20210A) mutation, antithrombin III deficiency. --- G20210A ---